Hiroyuki Kishino
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroyuki Kishino.
Bioorganic & Medicinal Chemistry Letters | 2009
Takao Suzuki; Minoru Moriya; Toshihiro Sakamoto; Takuya Suga; Hiroyuki Kishino; Hidekazu Takahashi; Makoto Ishikawa; Keita Nagai; Yumiko Imai; Etsuko Sekino; Masahiko Ito; Hisashi Iwaasa; Akane Ishihara; Shigeru Tokita; Akio Kanatani; Nagaaki Sato; Takehiro Fukami
Optimization of high-throughput screening hit 1a led to the identification of a novel spiro-piperidine class of melanin-concentrating hormone 1 receptor (MCH-1R) antagonists. Compound 3c was identified as a highly potent and selective MCH-1R antagonist, which has an IC(50) value of 0.09 nM at hMCH-1R. The synthesis and structure-activity relationships of the novel spiro-piperidine MCH-1R antagonists are described.
Bioorganic & Medicinal Chemistry Letters | 2009
Hiroyuki Kishino; Minoru Moriya; Shunji Sakuraba; Toshihiro Sakamoto; Hidekazu Takahashi; Takao Suzuki; Ryuichi Moriya; Masahiko Ito; Hisashi Iwaasa; Norihiro Takenaga; Akane Ishihara; Akio Kanatani; Nagaaki Sato; Takehiro Fukami
A series of imidazo[1,2-a]pyridine derivatives was identified and evaluated for MCH1R binding and antagonistic activity. Introduction of a methyl substituent at the 3-position of imidazo[1,2-a]pyridine provided compounds with a significant improvement in MCH1R affinity. Representative compounds in this series exhibited good potency and brain exposure in rats.
Bioorganic & Medicinal Chemistry Letters | 2009
Minoru Moriya; Hiroyuki Kishino; Shunji Sakuraba; Toshihiro Sakamoto; Takuya Suga; Hidekazu Takahashi; Takao Suzuki; Masahiko Ito; Junko Ito; Ryuichi Moriya; Norihiro Takenaga; Hisashi Iwaasa; Akane Ishihara; Akio Kanatani; Takehiro Fukami
A series of 2-aminobenzimidazole-based MCH1R antagonists was identified by core replacement of the aminoquinoline lead 1. Subsequent modification of the 2- and 5-positions led to improvement in potency and intrinsic clearance. Compound 25 exhibited good plasma and brain exposure, and attenuated MCH induced food intake at 30mg/kg PO in rats.
Bioorganic & Medicinal Chemistry | 2011
Yuji Haga; Sayaka Mizutani; Akira Naya; Hiroyuki Kishino; Hisashi Iwaasa; Masahiko Ito; Junko Ito; Minoru Moriya; Nagaaki Sato; Norihiro Takenaga; Akane Ishihara; Shigeru Tokita; Akio Kanatani; Norikazu Ohtake
The design, synthesis and structure-activity relationships of a novel class of N-phenylpyridone MCH1R antagonists are described. The core part of the N-phenylpyridone structure was newly designed and the side chain moieties that were attached to the core part were extensively explored. As a result of optimization of the N-phenylpyridone leads, we successfully developed the orally available, and brain-penetrable MCH1R selective antagonist 7c, exhibiting excellent anti-obese effect in diet-induced obese (DIO) mice.
Archive | 2003
Minoru Moriya; Toshihiro Sakamoto; Hiroyuki Kishino; Akio Kanatani
Archive | 2006
Shunji Sakuraba; Minoru Kameda; Hiroyuki Kishino; Yuji Haga; Norikazu Otake; Minoru Moriya
Archive | 2007
Hiroyuki Kishino; Yuji Haga; Sayaka Mizutani; Minoru Moriya; Norikazu Otake
Bioorganic & Medicinal Chemistry | 2004
Takashi Yoshizumi; Hirobumi Takahashi; Norikazu Ohtake; Hideki Jona; Yoshiyuki Sato; Hiroyuki Kishino; Toshihiro Sakamoto; Satoshi Ozaki; Hiroyuki Takahashi; Yoshihiro Shibata; Yasuyuki Ishii; Michiyasu Saito; Megumu Okada; Takashi Hayama; Masaru Nishikibe
Archive | 2012
Hiroyuki Kishino; Sayaka Mizutani; Shunji Sakuraba; Nagaaki Sato
Archive | 2009
Hiroyuki Kishino; 博之 岸野; Nagaaki Sato; 長明 佐藤; Takao Suzuki; 鈴木 隆雄